Review
Open access
Sep 2026
Randomised phase III trials of cancer prevention drugs: a systematic review and prediction of trial success
Background Pharmacological cancer risk reduction has received far less investment than therapeutic oncology and only a few agents have entered routine practice. Understanding the predictors of positive outcomes of previous trials and issues faced is critical to future developments. Methods This systematic review (PROSP...
A. Xu-Vuillard, B. Duso, B. Arun et al.
· ESMO Open · 0 citations